Wellthy Therapeutics

Wellthy Therapeutics demonstrates Real World Outcomes to manage chronic conditions better with its Wellthy Care ™ Digital Therapeutics Platform

New Delhi, June 14, 2021: Wellthy Therapeutics, a leading digital therapeutics (DTx) company operating in Europe and Asia, recently conducted…

4 years ago

Wellthy Therapeutics’ data shows significant blood pressure reduction through digital therapeutic intervention in patients with hypertension.

This makes it the first digital therapeutics intervention to show results in participants with hypertension in India Mumbai, May 16,…

5 years ago

Cipla and Wellthy Therapeutics Announce Partnership to offer Digital Therapeutics for Diabetes and Cardiovascular Diseases

New Delhi, February 20, 2019: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) and Wellthy…

6 years ago

Wockhardt Hospital, SOBO launches “Diabetes Clinic”

Bangalore, November 23, 2018: With a growing number of diabetic patients in the country, there is a dire need for more…

6 years ago

Wellthy Therapeutics presents real-world evidence to show digital therapeutics can both improve patient outcomes and aid doctors in decision making

~ Results shared via an oral presentation and two poster presentations at the American Diabetes Association’s (ADA)78th Scientific Sessions ~ …

6 years ago

Senior Marketing Director – Biocon, Vasudev Tribhuvan, joins Wellthy Therapeutics

Mumbai, June 06, 2018: Wellthy Therapeutics (Wellthy) today announced the appointment of Vasudev V. Tribhuvan as Vice President, Partnerships &…

7 years ago

Wellthy Therapeutics presents groundbreaking results at the world’s largest diabetes technology conference

Clinical data presented by South Asia’s leading Digital Therapeutic company at the 11th International Conference on Advanced Technologies & Treatments…

7 years ago